102 related articles for article (PubMed ID: 4992362)
1. Fate of intravenously administered zinc chelates in man.
Rosoff B; Hart H; Methfessel AH; Spencer H
J Appl Physiol; 1971 Jan; 30(1):12-6. PubMed ID: 4992362
[No Abstract] [Full Text] [Related]
2. [Metabolism and toxicity of therapeutic chelating agents. 3. Effect of EDTA and DTPA on the excretion of endogenous zinc].
Havlicek F
Strahlentherapie; 1967 Oct; 134(2):296-305. PubMed ID: 4970734
[No Abstract] [Full Text] [Related]
3. [Metabolism and toxicity of therapeutic chelating agents. 4. Excretion and metabolic degradation of EDTA and DTPA].
Havlícek F; Bohne F; Zorn H
Strahlentherapie; 1968 Nov; 136(5):604-8. PubMed ID: 4974440
[No Abstract] [Full Text] [Related]
4. Preparation and prolonged tissue retention of liposome-encapsulated chelating agents.
Rahman YE; Rosenthal MW; Cerny EA; Moretti ES
J Lab Clin Med; 1974 Apr; 83(4):640-7. PubMed ID: 4206355
[No Abstract] [Full Text] [Related]
5. [Metabolism and toxicity of therapeutic chelating agents. I. Comparative studies on the excretion of EDTA and DTPA in the rat urine].
Harmuth-Hoene AE
Strahlentherapie; 1967 Sep; 134(1):110-22. PubMed ID: 4967657
[No Abstract] [Full Text] [Related]
6. [Influence of the Ca-complexes of aminopolycarboxylic acids on the excretion and distribution of zinc].
Eybl V; Sýkora J; Mertl F
Z Gesamte Exp Med Einschl Exp Chir; 1970 Aug; 152(4):274-83. PubMed ID: 4995887
[No Abstract] [Full Text] [Related]
7. Effect of chelating agents on the removal of zinc-65 in man.
Spencer H; Rosoff B
Health Phys; 1966 Apr; 12(4):475-80. PubMed ID: 4960023
[No Abstract] [Full Text] [Related]
8. Intracellular plutonium: removal by liposome-encapsulated chelating agent.
Rahman YE; Rosenthal MW; Cerny EA
Science; 1973 Apr; 180(4083):300-2. PubMed ID: 4633691
[TBL] [Abstract][Full Text] [Related]
9. [Metabolism and toxicity of therapeutic chelating agents. II. Effect of DTPA on the intestinal absorption of zinc].
Bohne F; Nigrović V; Harmuth-Hoene AE
Strahlentherapie; 1967 Oct; 134(2):293-5. PubMed ID: 5598697
[No Abstract] [Full Text] [Related]
10. [Metabolism and toxicity of therapeutic chelating agents. 8. Excretion of sodium, potassium, magnesium and zinc].
Dvorak P
Strahlentherapie; 1970 May; 139(5):611-8. PubMed ID: 4994080
[No Abstract] [Full Text] [Related]
11. Binding of EDTA, histidine and acetylsalicylic acid to zinc-protein complex in intestinal content, intestinal mucosa and blood plasma.
Suso FA; Edwards HM
Nature; 1972 Mar; 236(5344):230-2. PubMed ID: 4623207
[No Abstract] [Full Text] [Related]
12. The retention and distribution of 241Am and 65Zn, given as DTPA chelates in rats and of [14C]DTPA in rats and beagles.
Stevens W; Bruenger FW; Atherton DR; Buster DS; Howerton G
Radiat Res; 1978 Aug; 75(2):397-409. PubMed ID: 102009
[No Abstract] [Full Text] [Related]
13. Human zinc metabolism: advances in the modeling of stable isotope data.
Miller LV; Krebs NF; Hambidge KM
Adv Exp Med Biol; 1998; 445():253-69. PubMed ID: 9781394
[TBL] [Abstract][Full Text] [Related]
14. Effects of dietary EDTA and cadmium on absorption, excretion and retention of orally administered 65Zn in various tissues of zinc-deficient and normal goats and calves.
Powell GW; Miller WJ; Blackmon DM
J Nutr; 1967 Oct; 93(2):203-12. PubMed ID: 4964051
[No Abstract] [Full Text] [Related]
15. Absorption of 51Cr-EDTA in ulcerative colitis following rectal instillation.
Rask-Madsen J; Schwartz M
Scand J Gastroenterol; 1970; 5(5):361-8. PubMed ID: 4989516
[No Abstract] [Full Text] [Related]
16. [Decorporation of radionuclides. (Comparative studies with deferoxamine B and diethylenetriamine pentaacetic acid)].
Nigrovic V; Catsch A
Strahlentherapie; 1965 Oct; 128(2):283-7. PubMed ID: 5884887
[No Abstract] [Full Text] [Related]
17. Intestinal permeability in inflammatory bowel disease.
Casellas F; Aguadè S; Molero J
Am J Gastroenterol; 1986 Jun; 81(6):502. PubMed ID: 3085477
[No Abstract] [Full Text] [Related]
18. Distribution and retention of 169-YbCl3, 169-Yb-EDTA and 169-Yb-DTPA injected intravenously in the rat.
Baltrukiewiez Z; Burakowski T; Pogorzelska-Lis M
Acta Physiol Pol; 1975; 26(2):205-12. PubMed ID: 807085
[No Abstract] [Full Text] [Related]
19. [Behavior of radiozinc chelates in the mammal organism].
Catsch A; Du Khuong Le
Strahlentherapie; 1966 Aug; 130(4):557-66. PubMed ID: 5996855
[No Abstract] [Full Text] [Related]
20. [Use of technetium-labeled chelating compounds for the evaluation of their penetration into the dentin].
Pawlicka H; Ogiński M
Stomatol DDR; 1984 Jun; 34(6):321-6. PubMed ID: 6435290
[No Abstract] [Full Text] [Related]
[Next] [New Search]
